📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Novel immunotherapeutics against LGR5 to target multiple cancer types. (2024)

First Author: Chen HC

Attributed to: Understanding the role of CIDEB in hepatic lipid metabolism and the pathogenesis of NAFLD funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s44321-024-00121-2

PubMed Identifier: 39169164

Publication URI: http://europepmc.org/abstract/MED/39169164

Type: Journal Article/Review

Volume: 16

Parent Publication: EMBO molecular medicine

Issue: 9

ISSN: 1757-4676